Abstract: Twenty years after its development, antibody phage display using filamentous bacteriophage represents the most successful in vitro antibody selection technology. Initially, its development was encouraged by the unique possibility of directly generating recombinant human antibodies for therapy. Today, antibody phage display has been developed as a robust technology offering great potential for automation. Generation of monospecific binders provides a valuable tool for proteome research, leading to highly enhanced throughput and reduced costs. This review presents the phage display technology, application areas of antibodies in research, diagnostics and therapy and the use of antibody phage display for these applications.
Keywords: antibody; scFv; phage display; cancer; diagnostics; proteome research; panning
This is an open access article distributed under the
Creative Commons Attribution License which permits unrestricted use, distribution,
and reproduction in any medium, provided the original work is properly cited.
Export to BibTeX
MDPI and ACS Style
Schirrmann, T.; Meyer, T.; Schütte, M.; Frenzel, A.; Hust, M. Phage Display for the Generation of Antibodies for Proteome Research, Diagnostics and Therapy. Molecules 2011, 16, 412-426.
Schirrmann T, Meyer T, Schütte M, Frenzel A, Hust M. Phage Display for the Generation of Antibodies for Proteome Research, Diagnostics and Therapy. Molecules. 2011; 16(1):412-426.
Schirrmann, Thomas; Meyer, Torsten; Schütte, Mark; Frenzel, André; Hust, Michael. 2011. "Phage Display for the Generation of Antibodies for Proteome Research, Diagnostics and Therapy." Molecules 16, no. 1: 412-426.